Elevance Health Inc. (ELV) Tops Q3 EPS by 37c, Beats on Revenue
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- SanDisk stock rallies on AI optimism and Fed relief
Elevance Health Reports Third Quarter 2022 Results, Raises Full Year Outlook
October 19, 2022 6:00 AM EDTThird quarter GAAP net income was $6.68 per share, including net negative adjustment items of $0.85 per share. Adjusted net income was $7.53* per share. Operating revenue grew 11.5% over the prior year quarter to $39.6 billion. Operating gain grew 10.2% over the prior year quarter to $2.3 billion. Medical enrollment increased 2.2 million members year-over-year and 232 thousand members during the quarter to 47.3 million members. Fourth quarter 2022 dividend of $1.28 per share declared to shareholders.
INDIANAPOLIS--(BUSINESS WIRE)-- Elevance Health, Inc. (NYSE: ELV) reported third quarter 2022 results reflecting strong financial... More
